Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

PPAR research

Showing results (61-70 of 679) with videos related to

Pageof 68
Sort By:
PPAR Research|December 10, 2015
AICAR Protects against High Palmitate/High Insulin-Induced Intramyocellular Lipid Accumulation and Insulin Resistance in HL-1 Cardiac Cells by Inducing PPAR-Target Gene ExpressionRicardo Rodríguez-Calvo, Manuel Vázquez-Carrera, Luis Masana, et al.
PPAR Research|July 7, 2016
PPARγ Agonists as an Anti-Inflammatory Treatment Inhibiting Rotavirus Infection of Small Intestinal VilliDory Gómez, Natalia Muñoz, Rafael Guerrero, et al.
PPAR Research|January 24, 2018
Peroxisome Proliferator-Activated Receptors Associated with Nonalcoholic Fatty Liver DiseaseNan Wang, Rui Kong, Hui Luo, et al.
PPAR Research|April 25, 2009
PPAR and liver injury in HIV-infected patientsMaud Lemoine, Jacqueline Capeau, Lawrence Serfaty
PPAR Research|April 11, 2009
Peroxisome Proliferator-Activated Receptor delta: A Target with a Broad Therapeutic Potential for Drug DiscoveryFrancine M Gregoire
PPAR Research|August 7, 2008
PPARs in NeuroinflammationMichael K Racke, Paul D Drew
PPAR Research|September 26, 2008
Regulation of Cell Proliferation and Differentiation by PPARbeta/deltaRolf Müller, Markus Rieck, Sabine Müller-Brüsselbach
PPAR Research|August 30, 2008
PPARalpha Ligands as Antitumorigenic and Antiangiogenic AgentsAmbra Pozzi, Jorge H Capdevila
PPAR Research|March 28, 2009
Is PPARγ a prospective player in HIV-1-associated bone disease?Eoin J Cotter, Patrick W Mallon, Peter P Doran
PPAR Research|July 23, 2008
PPAR Ligands as Potential Modifiers of Breast Carcinoma OutcomesAncha Baranova
Pageof 68

Showing results (61-70 of 679) with videos related to

Sort By:
Pageof 68
PPAR Research|December 10, 2015
AICAR Protects against High Palmitate/High Insulin-Induced Intramyocellular Lipid Accumulation and Insulin Resistance in HL-1 Cardiac Cells by Inducing PPAR-Target Gene ExpressionRicardo Rodríguez-Calvo, Manuel Vázquez-Carrera, Luis Masana, et al.
PPAR Research|July 7, 2016
PPARγ Agonists as an Anti-Inflammatory Treatment Inhibiting Rotavirus Infection of Small Intestinal VilliDory Gómez, Natalia Muñoz, Rafael Guerrero, et al.
PPAR Research|January 24, 2018
Peroxisome Proliferator-Activated Receptors Associated with Nonalcoholic Fatty Liver DiseaseNan Wang, Rui Kong, Hui Luo, et al.
PPAR Research|April 25, 2009
PPAR and liver injury in HIV-infected patientsMaud Lemoine, Jacqueline Capeau, Lawrence Serfaty
PPAR Research|April 11, 2009
Peroxisome Proliferator-Activated Receptor delta: A Target with a Broad Therapeutic Potential for Drug DiscoveryFrancine M Gregoire
PPAR Research|August 7, 2008
PPARs in NeuroinflammationMichael K Racke, Paul D Drew
PPAR Research|September 26, 2008
Regulation of Cell Proliferation and Differentiation by PPARbeta/deltaRolf Müller, Markus Rieck, Sabine Müller-Brüsselbach
PPAR Research|August 30, 2008
PPARalpha Ligands as Antitumorigenic and Antiangiogenic AgentsAmbra Pozzi, Jorge H Capdevila
PPAR Research|March 28, 2009
Is PPARγ a prospective player in HIV-1-associated bone disease?Eoin J Cotter, Patrick W Mallon, Peter P Doran
PPAR Research|July 23, 2008
PPAR Ligands as Potential Modifiers of Breast Carcinoma OutcomesAncha Baranova
Pageof 68